$CCAP News

Keefe, Bruyette & Woods Downgrades Crescent Capital BDC to Market Perform, Lowers Price Target to $12

Crescent Capital BDC: I'm Much Less Optimistic Than Wall Street

Ladenburg Thalmann Maintains Buy on Crescent Capital BDC, Lowers Price Target to $14

B. Riley Securities Maintains Neutral on Crescent Capital BDC, Lowers Price Target to $12.5

Crescent Capital BDC, Inc. (CCAP) Q2 2026 Earnings Call Transcript

Crescent Capital BDC, Inc. 2026 Q2 - Results - Earnings Call Presentation

Crescent Capital BDC Q2 Adj. EPS $0.36 Misses $0.37 Estimate, Sales $36.323M Miss $37.316M Estimate

Keefe, Bruyette & Woods Maintains Outperform on Crescent Capital BDC, Lowers Price Target to $13

Oppenheimer Downgrades Crescent Capital BDC to Perform, Lowers Price Target to $16

Wells Fargo Maintains Equal-Weight on Crescent Capital BDC, Lowers Price Target to $12

Crescent Capital BDC, Inc. (CCAP) Q1 2026 Earnings Call Transcript

Crescent Capital BDC Q1 Adj. EPS $0.42, Inline, Sales $37.912M Miss $39.459M Estimate

Keefe, Bruyette & Woods Maintains Outperform on Crescent Capital BDC, Lowers Price Target to $15

Crescent Capital BDC: Additional Downside Risks Remain (Rating Downgrade)

B. Riley Securities Initiates Coverage On Crescent Capital BDC with Neutral Rating, Announces Price Target of $13.5

Crescent Capital BDC (CCAP) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Crescent Capital BDC (CCAP) Moves to Buy: Rationale Behind the Upgrade

Down 12% in 4 Weeks, Here's Why Crescent Capital BDC (CCAP) Looks Ripe for a Turnaround

Wells Fargo Maintains Equal-Weight on Crescent Capital BDC, Lowers Price Target to $13

Crescent Capital BDC Inc (CCAP) Q4 2025 Earnings Call Highlights: Strong Dividend Coverage Amid ...